BioSig Technologies, Inc. (BSGM) News

BioSig Technologies, Inc. (BSGM): $0.85

0.05 (+6.25%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter BSGM News Items

BSGM News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

BSGM News Highlights

  • BSGM's 30 day story count now stands at 2.
  • Over the past 13 days, the trend for BSGM's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • The most mentioned tickers in articles about BSGM are FUL, MO and MSCI.

Latest BSGM News From Around the Web

Below are the latest news stories about BioSig Technologies Inc that investors may wish to consider to help them evaluate BSGM as an investment opportunity.

Smith, Moore & Co. Buys Simplify Hedged Equity ETF, BlackRock Science and Technology Trust ...

Clayton, MO, based Investment company Smith, Moore & Co. (Current Portfolio) buys Simplify Hedged Equity ETF, BlackRock Science and Technology Trust II, Verizon Communications Inc, American Century Quality Diversified International, VanEck Morningstar Wide Moat ETF, sells Roman DBDR Tech Acquisition Corp, BTC iShares MSCI EAFE Min Vol Factor ETF, Merida Merger Corp I, Hemisphere Media Group Inc, Rio Tinto PLC during the 3-months ended 2021Q4, according to the most recent filings of the investmen

Yahoo | February 8, 2022

BioSig Awarded US Patent Claims for its PURE EP™ Noise-Filtering Technology

Westport, CT, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Claims address computer-implemented systems and methods for filtering noise from input cardiac signals using its PURE EP™ technologyThe Company now has 49 issued or allowed worldwide patents covering its novel technology for arrhythmia care BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the ful

Yahoo | January 26, 2022

BioSig to Present at the 27th Annual International AF Symposium

Westport, CT, Jan. 07, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM ) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that the Company would be presenting at the 27th Annual International Atrial Fibrillation Symposium on January 13-15, 2022. Clinical observations collected with BioSig''s PURE EP System will be presented by DJ Lakkireddy, M.D., Kansas City Heart Rhythm Institute at HCA Midwest Health during Spotlight Session : Complex AF Case Study Utilizing a New Standard in Signal Processing on January 13, 2022, from 8:30-9:30 AM ET. "Dr. Lakkireddy is highly regarded for his passionate co...

Benzinga | January 7, 2022

BioSig to Present at the 24th Annual Virtual Needham Growth Conference

Westport, CT, Jan. 06, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM ) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that it it will present at the 24 th Annual Virtual Needham Growth Conference on Friday, January 14 th , 2022 at 4:15 PM ET. To register for the live webcast of the event, please click here . A replay of the presentation will also be available on the BioSig Website . For parties interested in scheduling a one-on-one meeting with BioSig management, please contact your Needham representative. The PURE EP is an FDA 510(k) cleared non-invasive class II device that aims to drive ...

Benzinga | January 6, 2022

BioSig Technologies, Inc. Selects Access Strategy Partners to Accelerate Commercial Sales

Leading healthcare management firm to enhance the Company’s market access strategy as it expands the installation base of its signal processing technology for arrhythmia care Leading healthcare management firm to enhance the Company’s market access strategy as it expands the installation base of its signal processing technology for arrhythmia care

Intrado Digital Media | December 21, 2021

BioSig Expands Its Clinical Footprint In Florida

The Company’s signal processing technology for arrhythmia care is being installed in a leading HCA Healthcare-operated facility in Southeast FloridaWestport, CT, Dec. 16, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that it is installing a PURE EP™ Sy

Yahoo | December 16, 2021

Millennium Management LLC Acquires New Stake in BioSig Technologies, Inc. (NASDAQ:BSGM)

Millennium Management LLC bought a new position in BioSig Technologies, Inc. (NASDAQ:BSGM) in the second quarter, according to its most recent disclosure with the SEC. The firm bought 214,556 shares of the companys stock, valued at approximately $828,000. Millennium Management LLC owned about 0.67% of BioSig Technologies as of its most recent SEC filing. Other [] The post Millennium Management LLC Acquires New Stake in BioSig Technologies, Inc. (NASDAQ:BSGM) appeared first on ETF Daily News .

ETF Daily News | December 13, 2021

BioSig to Host Conference Call on December 21, 2021

Westport, CT, Dec. 13, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that it would host a conference call on Tuesday, December 21, 2021, at 2 PM ET. Conference Call DetailsDate: Tuesday, December 21, 2021Time: 2:00 PM Eastern Time (ET)Dial-in number fo

Yahoo | December 13, 2021

State Street Corp Has $401,000 Holdings in BioSig Technologies, Inc. (NASDAQ:BSGM)

State Street Corp trimmed its position in BioSig Technologies, Inc. (NASDAQ:BSGM) by 72.4% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 103,773 shares of the companys stock after selling 272,380 shares during the quarter. State Street Corp owned 0.32% of BioSig []

Dakota Financial News | December 7, 2021

BioSig to Participate in the Benzinga All Access Event on December 14, 2021

Westport, CT, Dec. 06, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that Natasha Drapeau, Executive Vice President of BioSig Technologies, Inc., would be presenting at the Benzinga All Access event on Tuesday, December 14, 2021, at 9:40 am EST.

Intrado Digital Media | December 6, 2021


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6696 seconds.